Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jalz.2018.03.004 | DOI Listing |
J Rural Health
January 2025
Department of Informatics and Health Data Science, Miller School of Medicine, University of Miami, Miami, USA.
Biol Sex Differ
November 2024
Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
J Neurophysiol
December 2024
Department of Psychology and NeuroscienceTemple University, Philadelphia, Pennsylvania, United States.
Am J Physiol Heart Circ Physiol
December 2024
Department of Pharmacology, University of California, Davis, California, United States.
JAMA Intern Med
December 2024
Division of Geriatric Medicine, Division of Health Systems Science, UMass Chan Medical School, Worcester, Massachusetts.
Importance: Individuals with Alzheimer disease (AD) and Alzheimer disease-related dementias (ADRD) may be at increased risk for adverse outcomes relating to inappropriate prescribing of certain high-risk medications, including antipsychotics, sedative-hypnotics, and strong anticholinergic agents.
Objective: To evaluate the effect of a patient/caregiver and prescriber-mailed educational intervention on potentially inappropriate prescribing to patients with AD or ADRD.
Design, Setting, And Participants: This prospective, open-label, pragmatic randomized clinical trial, embedded in 2 large national health plans, was conducted from April 2022 to June 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!